US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 28.070
  • -0.310-1.09%
Close May 14 16:00 ET
  • 28.060
  • -0.010-0.04%
Post 19:45 ET
12.66BMarket Cap15.77P/E (TTM)

Royalty Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-16.96%567.98M
5.24%2.35B
5.36%596.07M
-6.48%536.31M
0.42%538.2M
21.69%683.97M
-2.28%2.24B
-1.73%565.75M
-2.10%573.46M
-3.43%535.96M
Operating revenue
-18.53%541.55M
1.67%2.2B
-4.30%523.3M
-7.93%508.91M
-3.16%501.55M
21.94%664.69M
-3.30%2.16B
-1.98%546.83M
-2.90%552.76M
-4.72%517.89M
Cost of revenue
Gross profit
Operating expense
213.05%641.75M
-34.38%862.4M
-103.89%-16.83M
0.95%384.87M
82.95%289.36M
-40.12%205M
53.05%1.31B
2.44%432.58M
34.85%381.25M
183.25%158.16M
Selling and administrative expenses
-32.72%57.65M
9.87%249.75M
-19.18%59.19M
12.91%57.23M
-8.12%47.63M
66.27%85.7M
24.33%227.3M
58.64%73.23M
4.33%50.69M
15.41%51.84M
-General and administrative expense
-32.72%57.65M
9.87%249.75M
-19.18%59.19M
12.91%57.23M
-8.12%47.63M
66.27%85.7M
24.33%227.3M
58.64%73.23M
4.33%50.69M
15.41%51.84M
Research and development costs
0.00%500K
-70.64%52M
-99.01%500K
98.04%50.5M
-17.49%500K
-99.50%500K
-11.48%177.11M
-51.36%50.5M
-71.82%25.5M
-80.59%606K
Depreciation amortization depletion
----
--0
--0
--0
--0
----
-75.34%5.67M
--0
--0
--0
-Depreciation and amortization
----
--0
--0
--0
--0
----
-75.34%5.67M
--0
--0
--0
Other operating expenses
391.23%583.6M
-38.00%560.66M
-124.77%-76.51M
-9.15%277.14M
128.19%241.23M
-35.65%118.8M
99.68%904.24M
15.89%308.85M
121.32%305.06M
143.37%105.71M
Operating profit
-115.40%-73.77M
61.68%1.49B
360.23%612.9M
-21.21%151.44M
-34.13%248.84M
117.99%478.97M
-35.49%922.89M
-13.20%133.17M
-36.58%192.21M
-49.29%377.79M
Net non-operating interest income expense
-21.71%-36.82M
-4.81%-114.9M
-1,213.83%-40.76M
31.41%-22.6M
40.92%-21.3M
19.41%-30.25M
2.65%-109.63M
91.46%-3.1M
-2.73%-32.94M
-54.12%-36.05M
Non-operating interest income
-55.59%7.42M
-7.72%72.29M
-85.18%6.5M
66.99%23.44M
134.94%25.65M
75.28%16.7M
46.32%78.34M
312.19%43.85M
14.46%14.03M
-22.21%10.92M
Non-operating interest expense
-5.79%44.23M
-0.41%187.19M
0.64%47.26M
-2.01%46.03M
-0.04%46.95M
-0.24%46.95M
13.13%187.96M
-0.04%46.96M
5.98%46.98M
25.49%46.97M
Other net income (expense)
76.12%106.32M
155.36%322.83M
119.65%145.45M
-111.07%-6.77M
-17.39%123.79M
211.58%60.37M
-658.32%-583.2M
-1,067.15%-740.1M
224.31%61.15M
75.89%149.85M
Gain on sale of security
334.52%124.15M
460.20%315.69M
240.63%163.49M
-99.79%161K
-17.77%123.47M
154.17%28.57M
208.92%56.35M
-465.18%-116.25M
247.02%75.2M
122.11%150.15M
Earnings from equity interest
-140.89%-14.15M
421.88%28.88M
103.91%268K
-60.63%-5.22M
-204.48%-770K
8,616.88%34.61M
53.96%-8.97M
81.97%-6.86M
-218.26%-3.25M
-95.84%737K
Special income (charges)
----
--0
----
----
----
----
---615.83M
----
----
----
-Write off
----
--0
----
----
----
----
--615.83M
----
----
----
Other non- operating income (expenses)
-31.00%-3.69M
-47.32%-21.74M
-1,471.50%-18.31M
84.19%-1.71M
205.41%1.09M
-60.10%-2.81M
-159.86%-14.76M
75.83%-1.17M
-1,261.66%-10.8M
-867.29%-1.04M
Income before tax
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-81.46%230.06M
-1,236.61%-610.03M
-0.62%220.41M
-39.06%491.6M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-81.46%230.06M
-1,236.61%-610.03M
-0.62%220.41M
-39.06%491.6M
Net income continuous Operations
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-81.46%230.06M
-1,236.61%-610.03M
-0.62%220.41M
-39.06%491.6M
Minority interest income
-105.38%-9.05M
201.90%565.25M
245.02%223.25M
-35.75%49.96M
-33.88%123.71M
120.56%168.33M
-69.87%187.23M
-436.37%-153.95M
-35.13%77.76M
-48.88%187.09M
Net income attributable to the parent company
-98.60%4.78M
2,549.50%1.13B
208.39%494.34M
-49.45%72.11M
-25.25%227.63M
558.32%340.76M
-93.09%42.83M
-5,870.29%-456.08M
39.95%142.65M
-30.92%304.5M
Preferred stock dividends
Other preferred stock dividends
-392.73M
Net income attributable to common stockholders
-98.60%4.78M
3,466.40%1.53B
294.50%887.07M
-49.45%72.11M
-25.25%227.63M
558.32%340.76M
-93.09%42.83M
-5,870.29%-456.08M
39.95%142.65M
-30.92%304.5M
Basic earnings per share
-98.68%0.01
2,440.00%2.54
206.73%1.11
-50.00%0.16
-27.14%0.51
533.33%0.76
-93.29%0.1
-1.04
33.33%0.32
-35.19%0.7
Diluted earnings per share
-98.68%0.01
2,430.00%2.53
174.96%1.1
-50.00%0.16
-28.57%0.5
533.33%0.76
-93.29%0.1
-122.01%-1.4675
33.33%0.32
-35.19%0.7
Dividend per share
5.00%0.21
5.26%0.8
5.26%0.2
5.26%0.2
5.26%0.2
5.26%0.2
11.76%0.76
11.76%0.19
11.76%0.19
11.76%0.19
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -16.96%567.98M5.24%2.35B5.36%596.07M-6.48%536.31M0.42%538.2M21.69%683.97M-2.28%2.24B-1.73%565.75M-2.10%573.46M-3.43%535.96M
Operating revenue -18.53%541.55M1.67%2.2B-4.30%523.3M-7.93%508.91M-3.16%501.55M21.94%664.69M-3.30%2.16B-1.98%546.83M-2.90%552.76M-4.72%517.89M
Cost of revenue
Gross profit
Operating expense 213.05%641.75M-34.38%862.4M-103.89%-16.83M0.95%384.87M82.95%289.36M-40.12%205M53.05%1.31B2.44%432.58M34.85%381.25M183.25%158.16M
Selling and administrative expenses -32.72%57.65M9.87%249.75M-19.18%59.19M12.91%57.23M-8.12%47.63M66.27%85.7M24.33%227.3M58.64%73.23M4.33%50.69M15.41%51.84M
-General and administrative expense -32.72%57.65M9.87%249.75M-19.18%59.19M12.91%57.23M-8.12%47.63M66.27%85.7M24.33%227.3M58.64%73.23M4.33%50.69M15.41%51.84M
Research and development costs 0.00%500K-70.64%52M-99.01%500K98.04%50.5M-17.49%500K-99.50%500K-11.48%177.11M-51.36%50.5M-71.82%25.5M-80.59%606K
Depreciation amortization depletion ------0--0--0--0-----75.34%5.67M--0--0--0
-Depreciation and amortization ------0--0--0--0-----75.34%5.67M--0--0--0
Other operating expenses 391.23%583.6M-38.00%560.66M-124.77%-76.51M-9.15%277.14M128.19%241.23M-35.65%118.8M99.68%904.24M15.89%308.85M121.32%305.06M143.37%105.71M
Operating profit -115.40%-73.77M61.68%1.49B360.23%612.9M-21.21%151.44M-34.13%248.84M117.99%478.97M-35.49%922.89M-13.20%133.17M-36.58%192.21M-49.29%377.79M
Net non-operating interest income expense -21.71%-36.82M-4.81%-114.9M-1,213.83%-40.76M31.41%-22.6M40.92%-21.3M19.41%-30.25M2.65%-109.63M91.46%-3.1M-2.73%-32.94M-54.12%-36.05M
Non-operating interest income -55.59%7.42M-7.72%72.29M-85.18%6.5M66.99%23.44M134.94%25.65M75.28%16.7M46.32%78.34M312.19%43.85M14.46%14.03M-22.21%10.92M
Non-operating interest expense -5.79%44.23M-0.41%187.19M0.64%47.26M-2.01%46.03M-0.04%46.95M-0.24%46.95M13.13%187.96M-0.04%46.96M5.98%46.98M25.49%46.97M
Other net income (expense) 76.12%106.32M155.36%322.83M119.65%145.45M-111.07%-6.77M-17.39%123.79M211.58%60.37M-658.32%-583.2M-1,067.15%-740.1M224.31%61.15M75.89%149.85M
Gain on sale of security 334.52%124.15M460.20%315.69M240.63%163.49M-99.79%161K-17.77%123.47M154.17%28.57M208.92%56.35M-465.18%-116.25M247.02%75.2M122.11%150.15M
Earnings from equity interest -140.89%-14.15M421.88%28.88M103.91%268K-60.63%-5.22M-204.48%-770K8,616.88%34.61M53.96%-8.97M81.97%-6.86M-218.26%-3.25M-95.84%737K
Special income (charges) ------0-------------------615.83M------------
-Write off ------0------------------615.83M------------
Other non- operating income (expenses) -31.00%-3.69M-47.32%-21.74M-1,471.50%-18.31M84.19%-1.71M205.41%1.09M-60.10%-2.81M-159.86%-14.76M75.83%-1.17M-1,261.66%-10.8M-867.29%-1.04M
Income before tax -100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M-81.46%230.06M-1,236.61%-610.03M-0.62%220.41M-39.06%491.6M
Income tax 0000000000
Net income -100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M-81.46%230.06M-1,236.61%-610.03M-0.62%220.41M-39.06%491.6M
Net income continuous Operations -100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M-81.46%230.06M-1,236.61%-610.03M-0.62%220.41M-39.06%491.6M
Minority interest income -105.38%-9.05M201.90%565.25M245.02%223.25M-35.75%49.96M-33.88%123.71M120.56%168.33M-69.87%187.23M-436.37%-153.95M-35.13%77.76M-48.88%187.09M
Net income attributable to the parent company -98.60%4.78M2,549.50%1.13B208.39%494.34M-49.45%72.11M-25.25%227.63M558.32%340.76M-93.09%42.83M-5,870.29%-456.08M39.95%142.65M-30.92%304.5M
Preferred stock dividends
Other preferred stock dividends -392.73M
Net income attributable to common stockholders -98.60%4.78M3,466.40%1.53B294.50%887.07M-49.45%72.11M-25.25%227.63M558.32%340.76M-93.09%42.83M-5,870.29%-456.08M39.95%142.65M-30.92%304.5M
Basic earnings per share -98.68%0.012,440.00%2.54206.73%1.11-50.00%0.16-27.14%0.51533.33%0.76-93.29%0.1-1.0433.33%0.32-35.19%0.7
Diluted earnings per share -98.68%0.012,430.00%2.53174.96%1.1-50.00%0.16-28.57%0.5533.33%0.76-93.29%0.1-122.01%-1.467533.33%0.32-35.19%0.7
Dividend per share 5.00%0.215.26%0.85.26%0.25.26%0.25.26%0.25.26%0.211.76%0.7611.76%0.1911.76%0.1911.76%0.19
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg